...
【24h】

Glucocorticoid treatment--effect on adrenal medullary catecholamine production.

机译:对肾上腺糖皮质激素治疗,效果髓儿茶酚胺生产。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Glucocorticoid and epinephrine are important stress hormones secreted from the adrenal gland during critical illness. Adrenal glucocorticoid stimulates phenylethanolamine N-methyltransferase (PNMT) to convert norepinephrine to epinephrine in the adrenal medulla. Glucocorticoid is sometimes used in catecholamine-resistant septic shock in critically ill patients. By suppressing adrenal glucocorticoid production, glucocorticoid therapy might also reduce the secretion of epinephrine during stress. To investigate this, we used a mouse model subjected to glucocorticoid therapy under basal conditions (experiment 1) and during stress (experiment 2). In experiment 1, pellets containing 0% to 8% dexamethasone were implanted subcutaneously in mice for 4 weeks. In experiment 2, animals received 14 days of intraperitoneal injections of normal saline, low- or high-dose dexamethasone, followed by 2 h of restraint. We found that in experiment 1, adrenal corticosterone did not differ with dexamethasone treatment. Phenylethanolamine N-methyltransferase messenger RNA levels and adrenal catecholamines were highest in the 8% dexamethasone group. Compared with experiment 1, restrained control mice in experiment 2 had high adrenal corticosterone, which decreased with dexamethasone. Phenylethanolamine N-methyltransferase messenger RNA content doubled with restraint but decreased with dexamethasone treatment. As in experiment 1, adrenal catecholamine content increased significantly with dexamethasone treatment. We conclude that without stress, when adrenocorticotropic hormone is low, high doses of exogenous dexamethasone stimulate PNMT and catecholamine synthesis, likely independently of adrenal corticosterone concentration. After stress, adrenocorticotropic hormone levels are elevated, and exogenous dexamethasone suppresses endogenous corticosterone and PNMT production. Nonetheless, catecholamines increase, possibly due to direct neural stimulation, which may override the hormonal regulation of epinephrine synthesis during stress.
机译:糖皮质激素和肾上腺素是重要的应激激素肾上腺的分泌在至关重要的疾病。刺激phenylethanolamine N-methyltransferase(PNMT)将去甲肾上腺素,肾上腺素肾上腺髓质。有时用于catecholamine-resistant感染性危重患者的休克。肾上腺糖皮质激素生产、糖皮质激素治疗也可能减少的分泌肾上腺素在压力。我们使用一个小鼠模型接受糖皮质激素治疗基底条件下(实验1)在压力(实验2)。在实验1中,颗粒含有0%到8%地塞米松在小鼠皮下植入4周。实验2,动物收到了14天腹腔注射生理盐水,低-或大剂量地塞米松,其次是2 h克制。皮质甾酮与地塞米松没有差别治疗。信使RNA水平和肾上腺儿茶酚胺最高的8%地塞米松组。与实验1相比,抑制控制老鼠实验2中有很高的肾上腺皮质甾酮,减少地塞米松。N-methyltransferase信使RNA含量翻了一倍与地塞米松进行克制,但减少了治疗。儿茶酚胺含量显著增加与地塞米松治疗。没有压力,当促肾上腺皮质激素低,高剂量的外源性地塞米松吗刺激PNMT和儿茶酚胺合成,可能独立于肾上腺皮质甾酮浓度。激素水平升高,外生地塞米松抑制内源性皮质甾酮和PNMT生产。儿茶酚胺增加,可能是由于直接神经刺激,这可能会覆盖激素调节肾上腺素合成在压力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号